Back in the fifties, scientist didn't know much about the chemical make up of marijuana. They tested it as an agent against various infections, but their experiments never reached the practical stage. Half a century later, researchers are able to look more closely at the potential medicinal properties of the plant; however, they are still unsure of how exactly the cannabinoids work and how effective they would end up being. More research and experimentation is needed if they expect to transition it into systemic antibiotics. Still, strides are being made. Scientists say THC could be ready for use in the near(er) future as a combatant against methicillin-resistant Staphylococcus aureus (MRSA), an often fatal bacteria responsible for difficult-to-treat infections in humans, commonly found in hospitals or jails, where the residents have open wounds, invasive devices, and weakened immune systems. The compound would serve as a topical agent, preventing microbes from colonizing on the skin. Whatever name you choose to call it—pot, reefer, weed, hemp—cannabis could end up being the drug for microbial strains that no other drugs can cure.